A Phase II Trial Evaluating the Safety and Effectiveness of the AastromReplicell System for Augmentation of Low-Dose Blood Stem Cell Transplantation
Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1703137
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2001
Authors
Publisher
Springer Science and Business Media LLC